Celanese Corp
Company snapshot
A consistent view of the latest supported company value and reported operating results.
Fundamental lens
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is negative. As of 2026-06-30.
Trailing-twelve-month operating cash flow less capital expenditures is positive. As of 2026-06-30.
Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-06-30.
Comparable retained change history is not available through this reader.
How this lens works
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Market summary
Completed-session reference prices from IEX for Oct 16, 2026.
Price statistics
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Price history
Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.
Derived reference metrics are omitted for this listing because the required history-quality checks did not clear for the full retained window.
About this market data
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.
Listing & sources
Ticker: CE · Exchange: NYSE · Common Stock, par value $0.0001 per share
SEC issuer CIK: 0001306830
Listing source refreshed: 2026-09-13
Financials
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
Income statement
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-12-31 | 2024-12-31 | 2023-12-31 | FY 2024 · 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $9.71B Filed 2026-08-05 | $9.54B Filed 2026-02-24 | $10.27B Filed 2026-02-24 | $10.93B Filed 2026-02-24 | $9.67B Filed 2025-02-21 |
| Cost of revenue | $7.68B Filed 2026-08-05 | $7.59B Filed 2026-02-24 | $7.93B Filed 2026-02-24 | $8.34B Filed 2026-02-24 | $7.29B Filed 2025-02-21 |
| Gross profit | $2.03B Filed 2026-08-05 | $1.95B Filed 2026-02-24 | $2.34B Filed 2026-02-24 | $2.58B Filed 2026-02-24 | $2.38B Filed 2025-02-21 |
| Operating income | -$692M Filed 2026-08-05 | -$786M Filed 2026-02-24 | -$720M Filed 2026-02-24 | $1.67B Filed 2026-02-24 | $1.38B Filed 2025-02-21 |
| Pretax income | -$1.12B Filed 2026-08-05 | -$1.22B Filed 2026-02-24 | -$1.02B Filed 2026-02-24 | $1.16B Filed 2026-02-24 | $1.42B Filed 2025-02-21 |
| Income tax expense | $22M Filed 2026-08-05 | -$90M Filed 2026-02-24 | $507M Filed 2026-02-24 | -$795M Filed 2026-02-24 | -$489M Filed 2025-02-21 |
| Net income | -$1.17B Filed 2026-08-05 | -$1.17B Filed 2026-02-24 | -$1.54B Filed 2026-02-24 | $1.94B Filed 2026-02-24 | $1.89B Filed 2025-02-21 |
| Diluted EPS | Unavailable | -$10.64 Filed 2026-02-24 | -$14.11 Filed 2026-02-24 | $17.76 Filed 2026-02-24 | $17.34 Filed 2025-02-21 |
| Diluted shares | Unavailable | 109.53M Filed 2026-02-24 | 109.27M Filed 2026-02-24 | 109.38M Filed 2026-02-24 | 109.24M Filed 2025-02-21 |
Balance sheet
| Metric | FY 2025 · 2025-12-31 | 2024-12-31 | 2023-12-31 | FY 2024 · 2022-12-31 |
|---|---|---|---|---|
| Cash | Unknown | Unknown | Unknown | $1.51B Filed 2023-02-24 |
| Current assets | $5.69B Filed 2026-02-24 | $5.13B Filed 2026-02-24 | $6.22B Filed 2025-02-21 | $6.61B Filed 2024-02-23 |
| Current liabilities | $3.68B Filed 2026-02-24 | $3.89B Filed 2026-02-24 | $4.07B Filed 2025-02-21 | $4.07B Filed 2024-02-23 |
| Total assets | $21.7B Filed 2026-02-24 | $22.84B Filed 2026-02-24 | $26.6B Filed 2025-02-21 | $26.27B Filed 2024-02-23 |
| Stockholders’ equity | $4.05B Filed 2026-02-24 | $5.13B Filed 2026-02-24 | $7.07B Filed 2026-02-24 | $5.64B Filed 2025-02-21 |
Cash flow
| Metric | TTM · 2026-06-30 | FY 2025 · 2025-12-31 | 2024-12-31 | 2023-12-31 | FY 2024 · 2022-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | $984M Filed 2026-08-05 | $1.15B Filed 2026-02-24 | $966M Filed 2026-02-24 | $1.9B Filed 2026-02-24 | $1.82B Filed 2025-02-21 |
| Depreciation & amortization | $835M Filed 2026-08-05 | $760M Filed 2026-02-24 | $801M Filed 2026-02-24 | $706M Filed 2026-02-24 | $462M Filed 2025-02-21 |
| Capital expenditures | $276M Filed 2026-08-05 | $343M Filed 2026-02-24 | $435M Filed 2026-02-24 | $568M Filed 2026-02-24 | $543M Filed 2025-02-21 |
| Long-term debt issued | $1.63B Filed 2026-08-05 | $4.35B Filed 2026-02-24 | $328M Filed 2026-02-24 | $3B Filed 2026-02-24 | $10.77B Filed 2025-02-21 |
| Long-term debt repaid | $2.44B Filed 2026-08-05 | $4.65B Filed 2026-02-24 | $1.03B Filed 2026-02-24 | $3.66B Filed 2026-02-24 | $526M Filed 2025-02-21 |
| Dividends paid | $13M Filed 2026-08-05 | $13M Filed 2026-02-24 | $307M Filed 2026-02-24 | $305M Filed 2026-02-24 | $297M Filed 2025-02-21 |
| Stock repurchases | Unknown | Unknown | $0 Filed 2025-02-21 | $0 Filed 2025-02-21 | $17M Filed 2025-02-21 |
Calculated from the latest TTM financials
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Valuation
Reference valuation uses the latest retained completed-session IEX close and the latest supported SEC-reported share count for a simple single ordinary-share structure.
Open this stock in the Valuation Lab →
Shares outstanding: 109.75M · reported as of 2026-08-03 · filed 2026-08-05
The price is a source-scoped IEX reference close, not a consolidated U.S. market close. P/E and enterprise-value multiples are omitted unless compatible common-equity earnings and complete financing scope are established rather than inferred from adjacent statement fields.
Statistics
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Ownership
No reviewed company-level insider ownership record is available for this listing.